Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Disorder”

14,390 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 14,390 results

Large-scale testing (Phase 3)Ended earlyNCT01387932
What this trial is testing

HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer

Who this might be right for
Hepatocellular Carcinoma
Merit Medical Systems, Inc. 235
Testing effectiveness (Phase 2)UnknownNCT04880187
What this trial is testing

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Axcella Health, Inc 273
Not applicableNot Yet RecruitingNCT06060847
What this trial is testing

Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS)

Who this might be right for
Carcinoma, HepatocellularMetabolic Syndrome
Ospedale V. Fazzi 50
Testing effectiveness (Phase 2)UnknownNCT03941626
What this trial is testing

Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies

Who this might be right for
Esophagus CancerHepatomaGlioma+1 more
Shenzhen BinDeBio Ltd. 50
Not applicableStudy completedNCT00001885
What this trial is testing

Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis

Who this might be right for
HealthyPulmonary FibrosisRheumatoid Arthritis
National Heart, Lung, and Blood Institute (NHLBI) 400
Not applicableUnknownNCT03226717
What this trial is testing

Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy

Who this might be right for
Hepatitis C
Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT02966834
What this trial is testing

Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis

Who this might be right for
Cholestasis
GlaxoSmithKline 147
Testing effectiveness (Phase 2)Study completedNCT01265498
What this trial is testing

The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 283
Not applicableUnknownNCT03173287
What this trial is testing

Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI

Who this might be right for
Liver FibrosisMRIIVIM+1 more
University Hospital, Clermont-Ferrand 63
Post-approval studies (Phase 4)Study completedNCT03098121
What this trial is testing

Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection

Who this might be right for
Chronic Hepatitis C
Taoyuan General Hospital 40
Early research (Phase 1)Study completedNCT01839604
What this trial is testing

A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Who this might be right for
Advanced Adult Hepatocellular CarcinomaHepatocellular Carcinoma Metastatic
AstraZeneca 58
Testing effectiveness (Phase 2)Study completedNCT00914355
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 92
Not applicableStudy completedNCT02390232
What this trial is testing

Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
University Hospital, Toulouse 176
Not applicableStudy completedNCT01790984
What this trial is testing

How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)?

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Bruce A. Griffin 27
Not applicableStudy completedNCT02635347
What this trial is testing

Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study

Who this might be right for
Liver FailureCarcinoma, Hepatocellular
Rutgers, The State University of New Jersey 31
Large-scale testing (Phase 3)Study completedNCT00599326
What this trial is testing

Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda

Who this might be right for
Porphyria Cutanea Tarda
University of Texas Southwestern Medical Center 10
Not applicableStudy completedNCT07603726
What this trial is testing

Multimodal Intervention for GGT Reduction in Alcohol Use Disorder (GGT-AUD)

Who this might be right for
Alcohol Use Disorder (AUD)
Medical Center TOPMED 197
Not applicableUnknownNCT03064685
What this trial is testing

Risk Factors and Outcomes of Pyogenic Liver Abscess in Adult Liver Recipients: A Match Case Control Study

Who this might be right for
Liver Transplant Abscess
Hospital Italiano de Buenos Aires 126
Post-approval studies (Phase 4)UnknownNCT02900443
What this trial is testing

Mycophenolate Mofetil Versus Azathioprine in Treatment Naive Autoimmune Hepatitis

Who this might be right for
Autoimmune Hepatitis
Radboud University Medical Center 70
Not applicableActive Not RecruitingNCT03364621
What this trial is testing

Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy

Who this might be right for
Colorectal CancerColorectal Cancer MetastaticHepatic Metastases
University Health Network, Toronto 17
Next Page